Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,985
datasets available to search
ShareScore release 0.9.0
Dataset results
1,985 results for “Antigen”
Anti-CD19/CD22 Bispecific Chimeric Antigen Receptor（CAR)-T Cell Therapy for Measurable Residual Disease(MRD) Positive ALL
ClinicalTrials.gov study NCT03919526. IPD Sharing: NO. Countries: 1. Publications: 0.
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
ClinicalTrials.gov study NCT06757881. IPD Sharing: NO. Countries: 1. Publications: 0.
An Evaluation of IV Gamma Globulin As a Method to Improve Kidney Transplant Survival in Patients With End-Stage Renal Disease Who Are Highly Sensitized to Transplant Antigens
ClinicalTrials.gov study NCT00000935. IPD Sharing: YES. Countries: 1. Publications: 0.
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
ClinicalTrials.gov study NCT04975698. IPD Sharing: YES. Countries: 1. Publications: 0.
Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological Malignancies
ClinicalTrials.gov study NCT06462248. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Study of JV-213 Autologous CD79b-targeting Chimeric Antigen Receptor T-cell Therapy in Adults With Relapsed or Refractory B-cell Lymphomas
ClinicalTrials.gov study NCT05773040. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chimeric Antigen Receptor T-Cell (CAR-T) Cells in Patients With R/R T-LBL
ClinicalTrials.gov study NCT05554575. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Entecavir Prophylaxis for Hepatitis B Reactivation for CD20 Positive B-cell Lymphoma Patients With Resolved Hepatitis B (Negative Hepatitis B Surface Antigen, Positive Hepatitis B Core Antibody)
ClinicalTrials.gov study NCT05453435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 2 Study of Pembrolizumab+Carboplatin in Breast Related Cancer Antigens-related Metastatic Breast Cancer (PEMBRACA)
ClinicalTrials.gov study NCT03732391. IPD Sharing: NO. Countries: 1. Publications: 0.
4th Generation Chimeric Antigen Receptor T Cells Targeting Glypican-3
ClinicalTrials.gov study NCT03980288. IPD Sharing: NO. Countries: 1. Publications: 0.
Adoptive Transfer of Specific HCC Antigens CD8+ T Cells for Treating Patients With Relapsed/Advanced HCC
ClinicalTrials.gov study NCT03175705. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Screening for Prostate Cancer Among Those Prostate-specific Antigen Value Between 2.5 and 4.0 ng/mL
ClinicalTrials.gov study NCT04317625. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Long-Term Follow-Up Basket Study for Participants Treated With SynKIR Chimeric Antigen Receptor (CAR) T Cell Product
ClinicalTrials.gov study NCT06701201. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of CAR-BCMA, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against BCMA in Subjects With Multiple Myeloma
ClinicalTrials.gov study NCT05243212. IPD Sharing: Not stated. Countries: 1. Publications: 0.
B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic M
ClinicalTrials.gov study NCT06191887. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of CC-98633, BCMA-targeted Chimeric Antigen Receptor (CAR) T Cells, in Participants With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04394650. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of Erlotinib in Patients With Non-Metastatic Prostate Cancer With a Rising Prostate Specific Antigen (PSA) on Hormone Therapy
ClinicalTrials.gov study NCT00148772. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of Lewis Antigen Assay Combined With CA19-9 Assay to Assess Prognosis in Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT06515587. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Exploratory Study of CD19-targeted Chimeric Antigen Receptor T Cells(BZ019) for Relapsed and Refractory B-cell Lymphoma
ClinicalTrials.gov study NCT04067414. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)
ClinicalTrials.gov study NCT05284032. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.